Meta-analytic evidence of systematic bias in estimates of neuroleptic malignant syndrome incidence

Comprehensive Psychiatry

Volumn 48, Issue 2, 2007, Pages 205-211

  Gurrera, Ronald J ^a   Simpson, John C ^a   Tsuang, Ming T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MEDLINE; NEUROLEPTIC MALIGNANT SYNDROME; PUBLICATION; RISK FACTOR;

BIAS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; HUMANS; INCIDENCE; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 33846796353     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2006.10.004     Document Type: Article

References (45)

1. Gelenberg A.J., Bellinghausen B., Wojcik J.D., Falk W.E., and Farhadi A.M. Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized?. J Clin Psychiatry 50 (1989) 178-180
2. Delay J., Pichot P., Lempérière T., et al. Un neuroleptique majeur non phenothiazine et non reserpinique, l'haloperidol, dans le traitement des psychoses. Ann Med Psychol (Paris) 118 (1960) 145-152
3. Caroff S.N., and Mann S.C. Neuroleptic malignant syndrome. Med Clin North Am 77 (1993) 185-202
4. Spivak B., Maline D.I., Kozyrev V.N., Mester R., Neduva S.A., Ravilov R.S., et al. Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow. Eur Psychiatry 15 (2000) 330-333
5. Keck Jr. P.E., Pope Jr. H.G., and McElroy S.L. Declining frequency of neuroleptic malignant syndrome in a hospital population. Am J Psychiatry 148 (1991) 880-882
6. Adityanjee, Aderibigbe Y.A., and Mathews T. Epidemiology of neuroleptic malignant syndrome. Clin Neuropharmacol 22 (1999) 151-158
7. Buckley P.F., and Hutchinson M. Neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry 58 (1995) 271-273
8. Buckley P.F., and Hasan S. Atypical neuroleptic malignant syndrome and atypical antipsychotics. Am J Psychiatry 155 (1998) 1633
9. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al., for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283 (2000) 2008-2012
10. Sterne J.A.C., Egger M., and Smith G.D. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 323 (2001) 101-105
11. Chopra M.P., Prakash S.S., and Raguram R. The neuroleptic malignant syndrome: an Indian experience. Compr Psychiatry 40 (1999) 19-23
12. Naganuma H., and Fujii I. Incidence and risk factors in neuroleptic malignant syndrome. Acta Psychiatr Scand 90 (1994) 424-426
13. Modestin J., Toffler G., and Drescher J.P. Neuroleptic malignant syndrome: results of a prospective study. Psychiatry Res 44 (1992) 251-256
14. Lee M.K., Ong S.B., and Tan C.T. Neuroleptic malignant syndrome in Malaysia: a university hospital experience. Med J Malaysia 47 (1992) 200-207
15. Hermesh H., Aizenberg D., Weizman A., Lapidot M., Mayor C., and Munitz H. Risk for definite neuroleptic malignant syndrome: a prospective study in 223 consecutive inpatients. Br J Psychiatry 161 (1992) 254-257
16. Warner M.D., Peabody C.A., and Boutros N.N. A survey of neuroleptic malignant syndrome. [letter]. J Nerv Ment Dis 178 (1990) 664-665
17. Deng M.Z., Chen G.Q., and Phillips M.R. Neuroleptic malignant syndrome in 12 of 9792 Chinese inpatients exposed to neuroleptics: a prospective study. Am J Psychiatry 147 (1990) 1149-1155
18. Friedman J.H., Davis R., and Wagner R.L. Neuroleptic malignant syndrome. The results of a 6-month prospective study of incidence in a state psychiatric hospital. Clin Neuropharmacol 11 (1988) 373-377
19. Gelenberg A.J., Bellinghausen B., Wojcik J.D., Falk W.E., and Sachs G.S. A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. Am J Psychiatry 145 (1988) 517-518
20. Addonizio G., Susman V.L., and Roth S.D. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 143 (1986) 1587-1590
21. Shiloh R., Valevski A., Bodinger L., Misgav S., Aizenberg D., Dorfman-Etrog P., et al. Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients. Int Clin Psychopharmacol 18 (2003) 147-149
22. Rivera J.M., García-Bragado F., Iriarte L.M., Gutiérrez F.L., Salgado V., Andreu J., et al. Sindrome neuroleptico maligno. Analisis de 9 casos. Medicina Clinica 94 (1990) 121-125
23. Weller M., and Kornhuber J. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'. Br J Psychiatry 161 (1992) 855-856
24. Montoya A., Ocampo M., and Torres-Ruiz A. Neuroleptic malignant syndrome in Mexico. Can J Clin Pharmacol 10 (2003) 111-113
25. Boyer P. Neuroleptic malignant syndrome: the French data. Presented at the 139th Annual Meeting of the American Psychiatric Association, Washington, DC (1986)
26. Neppe V.M. The neuroleptic malignant syndrome. A priority system. S Afr Med J 65 (1984) 523-525
27. Singh G. The malignant neuroleptic syndrome (a review with report of 3 cases). Indian J Psychiatry 23 (1981) 179-183
28. Sukanova L. Maligni neuroleptiky syndrom. Ceskoslov Psychiatr 81 (1985) 91-95
29. Lazarus A., Mann S.C., and Caroff S.N. The neuroleptic malignant syndrome and related conditions (1989), American Psychiatric Press, Washington (DC)
30. Keck Jr. P.E., Sebastianelli J., Pope Jr. H.G., and McElroy S.L. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. J Clin Psychiatry 50 (1989) 352-355
31. Keck Jr. P.E., Pope Jr. H.G., and McElroy S.L. Frequency and presentation of neuroleptic malignant syndrome: a prospective study. Am J Psychiatry 144 (1987) 1344-1346
32. Pope Jr. H.G., Keck Jr. P.E., and McElroy S.L. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 143 (1986) 1227-1233
33. Shalev A., and Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand 73 (1986) 337-347
34. Amore M., and Montanari M. La sindrome maligna da neurolettici e sindromi correlate. Minerva Psichiatr 4 (1992) 259-283
35. Adityanjee, Singh S., Singh G., and Ong S. Spectrum concept of neuroleptic malignant syndrome. Br J Psychiatry 153 (1988) 107-111
36. Levenson J.L. Neuroleptic malignant syndrome. Am J Psychiatry 142 (1985) 1137-1145
37. Gurrera R.J., Chang S.S., and Romero J.A. A comparison of diagnostic criteria for neuroleptic malignant syndrome. J Clin Psychiatry 53 (1992) 56-62
38. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed., chapter 9 (1981), John Wiley & Sons, Inc, New York 138-159
39. Zar J.H. Biostatistical analysis. 2nd ed., chapter 22 (1984), Prentice-Hall, Inc, Englewood Cliffs (NJ)
40. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 315 (1997) 629-634
41. Sterne J.A.C., and Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 10 (2001) 1046-1055
42. Fleming J.A., and Hsieh C.-C. Introduction to epidemiologic research methods. In: Tsuang M.T., and Tohen M. (Eds). Textbook in psychiatric epidemiology. 2nd ed., chapter 1 (2002), Wiley-Liss, Inc, New York 3-33
43. McManus R.J., Wilson S., Delaney B.C., Fitzmaurice D.A., Hyde C.J., Tobias R.S., et al. Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews. BMJ 317 (1998) 1562-1563
44. Slevin S. Statistical analysis of epidemiologic data. 2nd ed. (1996), Oxford University Press, New York 9
45. Begg C.B., and Berlin J.A. Publication bias: a problem in interpreting medical data. J R Stat Soc A 151 Part 3 (1988) 419-463